Trials underway for Anti Radiation Meds.
TP508 is a drug that combats the deadly exposure and damage dealt by lethal radiation leading to a potential a reduction in lives lost and mitigated genetic variations to those who are in danger of being exposed and killed by radiation or for those who are already affected by it.
A research team from the University of Texas Medical Branch, reports that an injection of the drug TP508 given within 24 hours after exposure to radiation. even if to a potentially lethal level, appears to significantly increase survival and to delay mortality. The mechanism is believed to counteract the damage to the gastrointestinal system caused by radiation exposure.
The research team says that threat of nuclear war or any other incident involving nuclear exposure, with the power to kill millions of people, has increased the quest for countermeasures that will reduce the effects of radiation damage and will also keep victims alive for at least 24 hours from their first contact with any kind of nuclear radiation. This will provide enough time to get the proper help to the person in time.
The research team suggested that TP508, a modern peptide in clinical tests, may prevent adverse effects of the radiation based on its boost of wound healing and its unique beneficial effects on endothelial cells.The results display that the drug may be the most effective radiation counter that could be given to the victims within a single day after exposure to increase the chances of survival greatly, giving people time to get to a medical facility. Although the drug was previously been tested and used for the repair of tissues and to stimulate blood flow, it is now under a keen observation to find out how it would work to heal radiation effects.